Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RRX✓SelectedUSD · RRXGSK vs RRX performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs RRX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,657.0%
RRX return
+3,925.9%
Excess return
-2,268.9%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioRRXExcessAlpha
1D-2.7%+0.5%-3.2%-2.8%
7D-4.2%+4.3%-8.5%-4.8%
30D-7.5%-8.0%+0.5%-6.4%
3M-3.3%-22.0%+18.7%-0.3%
6M-9.3%-11.9%+2.6%-8.9%
YTD+1.6%+17.1%-15.5%-2.7%
1Y+25.5%+14.9%+10.6%+20.1%
3Y+49.3%+6.9%+42.4%+40.2%
5Y+46.7%+19.6%+27.1%+32.3%
10Y+76.8%+215.9%-139.1%+30.0%
All+1,657.0%+3,925.9%-2,268.9%+843.0%

Cumulative growth

Daily Returns

Daily percentage return beside RRX.

Daily Out/Under-Performance

Portfolio return minus RRX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded RRX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling